Adenocarcinoma of the Prostate
3 competing products in clinical development for Adenocarcinoma of the Prostate.
Pipeline by Phase
Phase 11
Phase 21
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| enzalutamide + abiraterone + prednisone | Astellas Pharma | Phase 3 | UNKNOWN | 36 |
| Enzalutamide | Astellas Pharma | Phase 2 | Completed | 35 |
| Enzalutamide + Goserelin acetate + Leuprolide acetate | Astellas Pharma | Phase 1 | Active | 33 |